|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192990-04
|
$165,747
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
(1) Intestinal Organoid Models for APC LOH
|
5R21CA208638-02
|
$192,406
|
GIARDINA, CHARLES
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
2U54CA163071-06
|
$1,427,230
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(6) Molecular mechanisms explaining premalignant changes in the etiology of melanoma
|
1R21CA208736-01A1
|
$146,000
|
MURPH, MANDI
|
UNIVERSITY OF GEORGIA
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
1R01CA216248-01
|
$565,675
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(PQ1) Epigenetic effects of the premalignant field
|
5R01CA208620-02
|
$372,671
|
TERADA, LANCE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
|
5R01CA208644-02
|
$377,438
|
CRITTENDEN, MARKA
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
|
1R01CA219880-01
|
$697,539
|
PALUCKA, ANNA KAROLINA
|
JACKSON LABORATORY
|
|
(PQ4) Elucidating Determinants of Susceptibility to Tumorigenesis in the Skin
|
5R21CA208298-02
|
$180,459
|
RAMSEY, MATTHEW
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer
|
5R01CA205632-02
|
$457,974
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
|
(PQ7) A multi-fluorescent intravital microscopy approach to study osteosarcoma
|
1R21CA208618-01A1
|
$191,221
|
INTINI, GIUSEPPE
|
HARVARD MEDICAL SCHOOL
|
|
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
|
1R01CA208735-01A1
|
$729,393
|
FELSHER, DEAN
|
STANFORD UNIVERSITY
|
|
(PQ8) BONE MARROW-ON-A-CHIP:AN INVITRO 3D MODEL OF BREAST CANCER DORMANCY
|
7R21CA208519-02
|
$199,013
|
GEORGE, STEVEN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
(PQ9) Dual Action RSK Inhibitor: Targeting Metastasis and Providing Cardioprotection
|
5R21CA208631-02
|
$137,120
|
LANNIGAN, DEBORAH
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle
|
5R21CA205437-03
|
$168,236
|
WANING, DAVID
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
|
5R01CA190092-04
|
$552,684
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
|
5R01CA185039-04
|
$373,436
|
JAN, LILY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
5R01CA184820-04
|
$386,650
|
DUBOIS, RAYMOND
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
(PQB-4) Single cell analysis strategy for monitoring drug responses of tumors
|
5R01CA190122-04
|
$571,080
|
TIAN, QIANG
|
INSTITUTE FOR SYSTEMS BIOLOGY
|
|
(PQB6)Elucidating metastasis by real-time monitoring and tagging of CTCs in GEMMs
|
5R01CA184956-04
|
$594,017
|
MANALIS, SCOTT
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
|
5R01CA185457-04
|
$640,378
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
|
5R01CA185138-04
|
$490,842
|
HWANG, EUN-SIL
|
DUKE UNIVERSITY
|
|
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ
|
5R01CA194697-03
|
$347,700
|
ZHANG, SIYUAN
|
UNIVERSITY OF NOTRE DAME
|
|
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells
|
5R01CA185151-04
|
$613,546
|
NOVINA, CARL
|
DANA-FARBER CANCER INST
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-08
|
$1,258,708
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192973-04
|
$191,836
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
|
5R01CA201250-02
|
$695,342
|
LARSON, STEVEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
15-PGDH in Cholangiocarcinogenesis
|
5R01CA102325-11
|
$344,269
|
WU, TONG
|
TULANE UNIVERSITY OF LOUISIANA
|
|
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192992-04
|
$158,966
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-08
|
$919,471
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
2U54CA163068-06
|
$1,656,304
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-12
|
$407,680
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
2017 Cell Contact and Adhesion Gordon Research Conference and Gordon Research Seminar
|
1R13CA216892-01
|
$3,750
|
MCCLATCHEY, ANDREA
|
GORDON RESEARCH CONFERENCES
|
|
2017 Directed Cell Migration Gordon Research Conference and Gordon Research Seminar
|
1R13CA213855-01
|
$2,000
|
MONTELL, DENISE
|
GORDON RESEARCH CONFERENCES
|
|
2017 international EMT society meeting
|
1R13CA221310-01
|
$2,000
|
YANG, JING
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
2017 Mammary Gland Biology Gordon Research Conference & Gordon Research Seminar
|
1R13CA216888-01
|
$10,000
|
FORD, HEIDE
|
GORDON RESEARCH CONFERENCES
|
|
3D Dynamic Contrast-Enhanced US for Monitoring Chemotherapy of Liver Metastasis
|
5R01CA195443-02
|
$252,908
|
WILLMANN, JUERGEN
|
STANFORD UNIVERSITY
|
|
A blood test to identify prostate cancer patients at risk for visceral metastasis
|
1R01CA218356-01
|
$620,500
|
POSADAS, EDWIN
|
CEDARS-SINAI MEDICAL CENTER
|
|
A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer
|
1R43CA210817-01A1
|
$152,589
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
A High-Throughput Model for Human Melanoma
|
5R01CA121118-09
|
$247,340
|
HOLMEN, SHERI
|
UNIVERSITY OF UTAH
|
|
A highly specific NIRF/PET probe for the detection of cancer and metastases
|
1R43CA210854-01A1
|
$224,958
|
Yang, Xinlin
|
IMOL RADIOPHARMACEUTICALS, LLC
|
|
A Microfluidics Approach to Investigate Tumor Cell Trafficking in Bone Marrow
|
1F32CA210540-01A1
|
$58,326
|
GLASER, DREW
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$151,467
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
A Nanopatterned Interdigitated Electrode Array Device for Anti-migratory Cancer Drug Screening
|
1R43CA221659-01
|
$225,000
|
Geisse, Nicholas
|
NANOSURFACE BIOMEDICAL, INC.
|
|
A nanosystem for tumor treatment and imaging
|
5R01CA188883-04
|
$404,625
|
RUOSLAHTI, ERKKI
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
A network platform to connect drug response and prognosis phenotypes for cancers
|
5R01CA196631-02
|
$395,911
|
LI, HU
|
MAYO CLINIC ROCHESTER
|
|
A new imaging approach to radiotherapy planning for lung cancer
|
5R01CA193050-03
|
$535,497
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|